Roopal Thakkar
EVP, R&D and CSO · AbbVie Inc.
Individual
- 2026
- Mar 3, 2026
- 2
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Roopal Thakkar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Perry C. Siatis - $9.52M in ABBV purchases and sales in the last 12 months
- Nicholas Donoghoe - $8.18M in ABBV purchases and sales in the last 12 months
- David Ryan Purdue - $1.22M in ABBV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Roopal Thakkar?
Roopal Thakkar is a corporate insider, tracked as EVP, R&D and CSO of AbbVie Inc. (ABBV). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Roopal Thakkar last file a Form 4?
The most recent primary Form 4 on record is dated 3 March 2026, one of 2 filings going back to 2026.
